| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/005 |
Elocta, Powder and solvent for solution for injection, 1500, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
1837.17 |
367.43 |
2204.6 |
4% |
10 |
1847.17 |
369.43 |
2216.6 |
16% |
25 |
1872.17 |
374.43 |
2246.6 |
|
НСР-15271/16.03.2018 Предварително изпълнение; КП-53/19.06.2019 и НСР-17246/14.11.2018 |
02.08.2019 |
02.08.2019 |
Активен |
16049 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/007 |
Elocta, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
3674.36 |
734.87 |
4409.23 |
4% |
10 |
3684.36 |
736.87 |
4421.23 |
16% |
25 |
3709.36 |
741.87 |
4451.23 |
|
НСР-15271/16.03.2018 Предварително изпълнение; КП-51/19.06.2019 и НСР-17244/14.11.2018 |
02.08.2019 |
02.08.2019 |
Активен |
16051 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/006 |
Elocta, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
2449.56 |
489.91 |
2939.47 |
4% |
10 |
2459.56 |
491.91 |
2951.47 |
16% |
25 |
2484.56 |
496.91 |
2981.47 |
|
НСР-15271/16.03.2018 Предварително изпълнение; КП-52/19.06.2019 и НСР-17245/14.11.2018 |
02.08.2019 |
02.08.2019 |
Активен |
16050 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/005 |
Elocta, Powder and solvent for solution for injection, 1500, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
1901.07 |
380.21 |
2281.28 |
4% |
10 |
1911.07 |
382.21 |
2293.28 |
16% |
25 |
1936.07 |
387.21 |
2323.28 |
|
НСР-15271/16.03.2018 Предварително изпълнение |
16.03.2018 |
02.04.2018 |
Неактивен |
16049 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/007 |
Elocta, Powder and solvent for solution for injection, 3000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
3802.13 |
760.43 |
4562.56 |
4% |
10 |
3812.13 |
762.43 |
4574.56 |
16% |
25 |
3837.13 |
767.43 |
4604.56 |
|
НСР-15271/16.03.2018 Предварително изпълнение |
16.03.2018 |
02.04.2018 |
Неактивен |
16051 |
| coagulation factor VIII (efmoroctocog alfa) |
EU/1/15/1046/006 |
Elocta, Powder and solvent for solution for injection, 2000, IU, Pack: 1 vial (powder) +1 pre-filled syringe (solvent) |
Swedish Orphan Biovitrum AB, Швеция |
Swedish Orphan Biovitrum AB (publ), Швеция |
2534.76 |
506.95 |
3041.71 |
4% |
10 |
2544.76 |
508.95 |
3053.71 |
16% |
25 |
2569.76 |
513.95 |
3083.71 |
|
НСР-15271/16.03.2018 Предварително изпълнение |
16.03.2018 |
02.04.2018 |
Неактивен |
16050 |
| Corifollitropin alfa |
EU/1/09/609/001 |
Elonva, Solution for injection, 100 µg/0.5ml, -, Pack: 1 pre-filled syringe + 1 needle |
Merck Sharp & Dohme B.V., Нидерландия |
N.V. Organon Kloosterstraat 6 5349 AB Oss The Netherlands; Organon (Ireland) Ltd. Drynam Road, Swords, Co. Dublin Ireland |
750.26 |
150.05 |
900.31 |
4% |
10 |
760.26 |
152.05 |
912.31 |
16% |
25 |
785.26 |
157.05 |
942.31 |
Промяна на обстоятелствата НСР-16938/04.10.2018 |
НСР-7655/01.12.2015. |
16.12.2015 |
02.11.2018 |
Активен |
3731 |
| Corifollitropin alfa |
EU/1/09/609/001 |
Elonva, Solution for injection, 100 µg/0.5ml, -, Pack: 1 pre-filled syringe + 1 needle |
Merck Sharp & Dohme Ltd., Обединено Кралство |
N.V. Organon Kloosterstraat 6 5349 AB Oss The Netherlands; Organon (Ireland) Ltd. Drynam Road, Swords, Co. Dublin Ireland |
750.26 |
150.05 |
900.31 |
4% |
10 |
760.26 |
152.05 |
912.31 |
16% |
25 |
785.26 |
157.05 |
942.31 |
|
НСР-7655/01.12.2015. |
16.12.2015 |
16.12.2015 |
Неактивен |
3731 |
| Corifollitropin alfa |
EU/1/09/609/001 |
Elonva, Solution for injection, 0.1, mg/ 0.5ml, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
N.V. Organon Kloosterstraat 6 5349 AB Oss The Netherlands; Organon (Ireland) Ltd. Drynam Road, Swords, Co. Dublin Ireland |
753.68 |
150.74 |
904.42 |
4% |
10 |
763.68 |
152.74 |
916.42 |
16% |
25 |
788.68 |
157.74 |
946.42 |
|
НСР-5956/01.04.2015. |
16.04.2015 |
16.04.2015 |
Неактивен |
3731 |
| Corifollitropin alfa |
EU/1/09/609/001 |
Elonva, Solution for injection, 0.1, mg/ 0.5ml, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
N.V. Organon Kloosterstraat 6 5349 AB Oss The Netherlands; Organon (Ireland) Ltd. Drynam Road, Swords, Co. Dublin Ireland |
769.87 |
153.97 |
923.84 |
4% |
10 |
779.87 |
155.97 |
935.84 |
16% |
25 |
804.87 |
160.97 |
965.84 |
корекц.НСР-4088/03.07.2014; промяна на обстоятелства НСР-4420/07.08.2014( в сила от 25.08.2014) |
НСР-3733/06.06.2014 |
04.07.2014 |
04.07.2014 |
Неактивен |
3731 |
| Corifollitropin alfa |
EU/1/09/609/001 |
Elonva, Solution for injection, 0.1, mg/ 0.5ml, Pack: 1 |
N.V. Organon, Нидерландия |
N.V. Organon Kloosterstraat 6 5349 AB Oss The Netherlands; Organon (Ireland) Ltd. Drynam Road, Swords, Co. Dublin Ireland |
777.54 |
155.51 |
933.05 |
4% |
10 |
787.54 |
157.51 |
945.05 |
16% |
25 |
812.54 |
162.51 |
975.05 |
|
КЦРР-2589/14.03.2013 |
02.04.2013 |
02.04.2013 |
Неактивен |
3731 |
| Corifollitropin alfa |
EU/1/09/609/002/ 25.01.2010 |
Elonva, Solution for injection, 0.15, mg/ 0.5ml, Pack: 1 |
Merck Sharp & Dohme Ltd., Обединено Кралство |
N.V. Organon Netherlands Organon (Ireland) Ltd. Ireland |
970.62 |
194.12 |
1164.74 |
4% |
10 |
980.62 |
196.12 |
1176.74 |
16% |
25 |
1005.62 |
201.12 |
1206.74 |
промяна на обстоятелства НСР-4419/07.08.2014 ( в сила от 25.08.2014) |
КЦРР-2059/24.01.2013 г |
25.02.2013 |
25.02.2013 |
Неактивен |
3715 |
| Corifollitropin alfa |
EU/1/09/609/002/ 25.01.2010 |
Elonva, Solution for injection, 0.15, mg/ 0.5ml, Pack: 1 |
N.V. Organon, Нидерландия |
N.V. Organon Netherlands Organon (Ireland) Ltd. Ireland |
1034.63 |
206.93 |
1241.56 |
4% |
10 |
1044.63 |
208.93 |
1253.56 |
16% |
25 |
1069.63 |
213.93 |
1283.56 |
|
КЦ-2768/28.09.2011 |
13.10.2011 |
13.10.2011 |
Неактивен |
3715 |
| Corifollitropin alfa |
EU/1/09/609/001/ 25.01.2010 |
Elonva, Solution for injection, 0.1, mg/ 0.5ml, Pack: 1 |
N.V. Organon, Нидерландия |
N.V. Organon Kloosterstraat 6 5349 AB OSS The Netherlands Organon (Ireland) Ltd. Drynam Road, Swords, Co. Dublin Ireland |
931.17 |
186.23 |
1117.4 |
4% |
10 |
941.17 |
188.23 |
1129.4 |
16% |
25 |
966.17 |
193.23 |
1159.4 |
|
КЦ-2427/06.07.2011 |
25.07.2011 |
25.07.2011 |
Неактивен |
3731 |
| Corifollitropin alfa |
EU/1/09/609/002 |
ELONVA, Solution for injection, 150 µg/0.5ml, -, Pack: 1 pre-filled syringe + 1 needle |
Merck Sharp & Dohme B.V., Нидерландия |
N.V. Organon Netherlands Organon (Ireland) Ltd. Ireland |
836.06 |
167.21 |
1003.27 |
4% |
10 |
846.06 |
169.21 |
1015.27 |
16% |
25 |
871.06 |
174.21 |
1045.27 |
Промяна на обстоятелствата НСР-16938/04.10.2018 |
НСР-5908/27.03.2015; НСР-9617/23.06.2016; НСР-12214/03.04.2017; НСР-14966/01.02.2018 |
16.02.2018 |
02.11.2018 |
Активен |
3715 |
| Corifollitropin alfa |
EU/1/09/609/002 |
ELONVA, Solution for injection, 150 µg/0.5ml, -, Pack: 1 pre-filled syringe + 1 needle |
Merck Sharp & Dohme Ltd., Обединено Кралство |
N.V. Organon Netherlands Organon (Ireland) Ltd. Ireland |
836.06 |
167.21 |
1003.27 |
4% |
10 |
846.06 |
169.21 |
1015.27 |
16% |
25 |
871.06 |
174.21 |
1045.27 |
|
НСР-5908/27.03.2015; НСР-9617/23.06.2016; НСР-12214/03.04.2017; НСР-14966/01.02.2018 |
16.02.2018 |
02.03.2018 |
Неактивен |
3715 |
| Corifollitropin alfa |
EU/1/09/609/002 |
ELONVA, Solution for injection, 150 µg/0.5ml, -, Pack: 1 pre-filled syringe + 1 needle |
Merck Sharp & Dohme Ltd., Обединено Кралство |
N.V. Organon Netherlands Organon (Ireland) Ltd. Ireland |
848.48 |
169.7 |
1018.18 |
4% |
10 |
858.48 |
171.7 |
1030.18 |
16% |
25 |
883.48 |
176.7 |
1060.18 |
|
НСР-5908/27.03.2015; НСР-9617/23.06.2016; НСР-12214/03.04.2017 |
18.04.2017 |
02.05.2017 |
Неактивен |
3715 |
| Corifollitropin alfa |
EU/1/09/609/002 |
ELONVA, Solution for injection, 150 µg/0.5ml, -, Pack: 1 pre-filled syringe + 1 needle |
Merck Sharp & Dohme Ltd., Обединено Кралство |
N.V. Organon Netherlands Organon (Ireland) Ltd. Ireland |
852.82 |
170.56 |
1023.38 |
4% |
10 |
862.82 |
172.56 |
1035.38 |
16% |
25 |
887.82 |
177.56 |
1065.38 |
|
НСР-5908/27.03.2015; НСР-9617/23.06.2016 |
02.08.2016 |
02.08.2016 |
Неактивен |
3715 |
| Corifollitropin alfa |
EU/1/09/609/002/ 25.01.2010 |
ELONVA, Solution for injection, 150 µg/0.5ml, -, Pack: 1 pre-filled syringe + 1 needle |
Merck Sharp & Dohme Ltd., Обединено Кралство |
N.V. Organon Netherlands Organon (Ireland) Ltd. Ireland |
858.61 |
171.72 |
1030.33 |
4% |
10 |
868.61 |
173.72 |
1042.33 |
16% |
25 |
893.61 |
178.72 |
1072.33 |
|
НСР-5908/27.03.2015 |
10.04.2015 |
10.04.2015 |
Неактивен |
3715 |
| Escitalopram |
20110534 |
Eloryqa, Film coated tablet, 10, mg, Pack: 30 |
Alkaloid – INT d.o.o., Словения |
Alcaloid-INT d.o.o. Slovenia |
9.94 |
1.99 |
11.93 |
7% |
0.7 |
10.64 |
2.13 |
12.77 |
20% |
1.99 |
12.63 |
2.53 |
15.16 |
|
КЦРР-1276/21.08.2012, корекц. КЦРР-1443/02.10.2012; НСР-18426/05.04.2019 |
06.09.2012 |
02.05.2019 |
Заличен |
1379 |
| Escitalopram |
20110534 |
Eloryqa, Film coated tablet, 10, mg, Pack: 30 |
Alkaloid – INT d.o.o., Словения |
Alcaloid-INT d.o.o. Slovenia |
9.94 |
1.99 |
11.93 |
7% |
0.7 |
10.64 |
2.13 |
12.77 |
20% |
1.99 |
12.63 |
2.53 |
15.16 |
|
КЦРР-1276/21.08.2012, корекц. КЦРР-1443/02.10.2012 |
06.09.2012 |
06.09.2012 |
Неактивен |
1379 |
| Oxaliplatin |
20060432 |
Eloxatin, Concentrate for solution for infusion, 100, mg, Pack: 1 |
Санофи-Авентис България ЕООД, България |
Aventis Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH Frankfurt am Main Германия |
212.89 |
42.58 |
255.47 |
4% |
8.52 |
221.41 |
44.28 |
265.69 |
16% |
25 |
246.41 |
49.28 |
295.69 |
промяна на обстоятелства НСР-4045/03.07.2014; корекц. Решение НСР-4512/15.08.2014; цената е заличена с решение НСР-6666/09.07.2015 (в сила от 02.08.2015 ) |
НСР-1313/03.10.2013 |
23.10.2013 |
23.10.2013 |
Заличен |
2166 |
| Oxaliplatin |
20060432 |
Eloxatin, Concentrate for solution for infusion, 50, mg, Pack: 1 |
Санофи-Авентис България ЕООД, България |
Aventis Pharma, Великобритания; Sanofi-Aventis Deutschland GmbH Frankfurt am Main Германия |
106.44 |
21.29 |
127.73 |
4% |
4.26 |
110.7 |
22.14 |
132.84 |
16% |
17.03 |
127.73 |
25.55 |
153.28 |
промяна на обстоятелства НСР-4045/03.07.2014; корекц. Решение НСР-4512/15.08.2014; цената е заличена с решение НСР-6665/09.07.2015 (в сила от 02.08.2015 ) |
НСР-1313/03.10.2013 |
23.10.2013 |
23.10.2013 |
Заличен |
2165 |
| Oxaliplatin |
3022/18,09,2008 |
Eloxatin, Powder for solution for infusion, 50, mg, Pack: 1 |
Санофи-Авентис България ЕООД, България |
Glaxo Wellcome Production- францияAventis Pharma Dagenham- Великобритания; Sanofi winthrop Industrie, Quetigny, Франция |
49.74 |
9.95 |
59.69 |
4% |
1.99 |
51.73 |
10.35 |
62.08 |
16% |
7.96 |
59.69 |
11.94 |
71.63 |
цената е заличена с решение НСР-862/09.08.2013 |
КЦРР-885/28.06.2012 |
19.07.2012 |
19.07.2012 |
Заличен |
1280 |
| Oxaliplatin |
3207/20,10,2008 |
Eloxatin, Concentrate for solution for infusion, 50, mg, Pack: 1 |
Санофи-Авентис България ЕООД, България |
Glaxo Wellcome Production- францияAventis Pharma Dagenham- Великобритания; Sanofi winthrop Industrie, Quetigny, Франция |
124.37 |
24.87 |
149.24 |
4% |
4.97 |
129.34 |
25.87 |
155.21 |
16% |
19.9 |
149.24 |
29.85 |
179.09 |
|
КЦРР-885/28.06.2012 |
19.07.2012 |
19.07.2012 |
Неактивен |
2165 |